Mangoceuticals Q2 net loss narrows to $1.31 million; revenue drops 59.11% to $68,757

Reuters2026/08/13 21:28

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Mangoceuticals posted Q2 net loss of USD 1.31 million, narrowing from USD 5.42 million a year earlier.
Revenue fell 59.11% to USD 68,757 from the prior-year quarter.
General and administrative expense dropped to USD 256,095 from USD 1.25 million; stock-based compensation sank to USD 92,417 from USD 3.12 million.
Six-month net loss narrowed to USD 4.72 million from USD 10.26 million; revenue declined to USD 136,621 from USD 277,415.
Entered a business combination agreement with Nuclea Energy on July 29, targeting a structure leaving former Nuclea holders about 96% ownership.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037873), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Mangoceuticals Q2 net loss narrows to $1.31 million; revenue drops 59.11% to $68,757

You may also like

Crypto prices